triple agonist glp-1 Polyagonists Enable Increasingly Effective Treatment of Obesity and Diabetes | DZD Dual and Triple Gut Peptide

Patients arent just patients with diabetes, or patients with kidney disease or patients with heart failure

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management

Common Side Effects and Their Causes The temporary slowing of gastric emptying explains many of the common side effects of GLP-1 medications

doi:10.1002/jcph.1765 168

Wegovy costs between $149 and $349 per month, making it one of the most affordable GLP-1 medications on the market

Right now, data on GLP-1 transfer into breast milk and possible effects on an infant is limited